3036004-28-8
3036004-28-8
Chemical Structure
Varsetatug
Synonym(s): CX-2051 antibody
- CAS No.: 3036004-28-8
- Formula:N/A
- Molecular Weight:(155.116 kDa)
SMILES: N/A
Biological Activity: Varsetatug (CX-2051 antibody) is a humanized IgG1κ monoclonal antibody inhibitor targeting EpCAM/TROP1/CD326. Varsetatug serves as the antibody component of the ADC compound CX-2051. It can be used in research on cancers including breast cancer, prostate cancer and ovarian cancer[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Varsetatug | 97% | Varsetatug (CX-2051 antibody) is a humanized IgG1κ monoclonal antibody inhibitor targeting EpCAM/TROP1/CD326. Varsetatug serves as the antibody component of the ADC compound CX-2051. It can be used in research on cancers including breast cancer, prostate cancer and ovarian cancer. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Internacionales D C. International Nonproprietary Names for Pharmaceutical Substances (INN)[J]. WHO Drug Information, 2025, 39(2).
- [2]. Baeuerle PA, et al. EpCAM (CD326) finding its role in cancer. Br J Cancer. 2007 Feb 12;96(3):417-23. doi: 10.1038/sj.bjc.6603494. Epub 2007 Jan 9. Erratum in: Br J Cancer. 2007 May 7;96(9):1491. [Content Brief]
